MENZELLA, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 387
AS - Asia 297
EU - Europa 27
SA - Sud America 12
AF - Africa 1
Totale 724
Nazione #
US - Stati Uniti d'America 385
CN - Cina 250
SG - Singapore 25
HK - Hong Kong 13
BR - Brasile 8
SE - Svezia 8
DE - Germania 3
FI - Finlandia 3
RU - Federazione Russa 3
AR - Argentina 2
BG - Bulgaria 2
GB - Regno Unito 2
ID - Indonesia 2
IT - Italia 2
KG - Kirghizistan 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
FR - Francia 1
GT - Guatemala 1
HU - Ungheria 1
JP - Giappone 1
LT - Lituania 1
MY - Malesia 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
VE - Venezuela 1
Totale 724
Città #
Portland 222
Santa Clara 39
Chandler 27
Ashburn 13
Hong Kong 13
Singapore 12
Fairfield 9
Nyköping 5
Shanghai 5
St Louis 4
Wilmington 4
Woodbridge 4
Cambridge 3
Houston 3
Moscow 3
Princeton 3
Ann Arbor 2
Beijing 2
Bishkek 2
Bremen 2
Helsinki 2
Jakarta 2
Modena 2
New York 2
Seattle 2
Sofia 2
Baião 1
Baoding 1
Barra do Corda 1
Capitão Poço 1
Cordoba 1
Dallas 1
Guapimirim 1
Guatemala City 1
Kilis 1
Lappeenranta 1
Lomas de Zamora 1
Maracaibo 1
Maringá 1
Munich 1
Norwalk 1
Nova Iguaçu 1
Olomouc 1
Petrópolis 1
Quito 1
San Mateo 1
Sharjah 1
Southwark 1
Toronto 1
Totale 412
Nome #
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial 543
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 108
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation 75
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy 3
Totale 729
Categoria #
all - tutte 2.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 2 0 9 0
2021/202244 0 2 1 5 2 0 3 2 4 1 8 16
2022/202354 11 7 1 3 11 5 0 7 5 0 0 4
2023/2024523 0 5 1 5 9 484 3 10 1 0 2 3
2024/202597 2 2 2 19 36 30 6 0 0 0 0 0
Totale 729